(Q74460431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Therapeutic efficacy of the lipid-lowering armamentarium: the clinical benefits of aggressive lipid-lowering therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

D B Hunninghake

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 February 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

9S-13S

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2898%2900040-0

10.1016/S0002-9343(98)00040-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9550501%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference